Company Profile
Syngene International Limited, a contract research and manufacturing company provides drug discovery and development services globally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry.
Its portfolio also includes discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals, and chemical, formulation, analytical, and clinical development services.
It provides lead generation, preclinical development, API, and drug product development services Clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services
Chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics. Its portfolio also includes biologics, and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization.
The company serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. Incorporated in 1993, the company is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.